Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  American Journal of Physiology - Lung cellular and Molecular Physiology

• Publication date

  2016-07-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1152/ajplung.00263.2015PMID 27233998PMCID PMC4967185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sirtuins in vascular diseases: Emerging roles and therapeutic potential.

  2015cited by this paper
• Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis

  2015cited by this paper
• Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human Pancreatic Ductal Adenocarcinoma

  2015cited by this paper
• Regulation of Oxidative Stress in Pulmonary Artery Endothelium. Modulation of Extracellular Superoxide Dismutase and NOX4 Expression Using Histone Deacetylase Class I Inhibitors.

  2015cited by this paper
• Therapeutic Efficacy of Valproic Acid in a Combined Monocrotaline and Chronic Hypoxia Rat Model of Severe Pulmonary Hypertension

  2015cited by this paper
• Acetyl-lysine erasers and readers in the control of pulmonary hypertension and right ventricular hypertrophy.

  2015cited by this paper
• Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration.

  2014cited by this paper
• Restoration of Impaired Endothelial Myocyte Enhancer Factor 2 Function Rescues Pulmonary Arterial Hypertension

  2014cited by this paper
• Histone Deacetylase Inhibition with Trichostatin a does not Reverse Severe Angioproliferative Pulmonary Hypertension in Rats (2013 Grover Conference Series)

  2014cited by this paper
• Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis

  2014cited by this paper
• Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension.

  2014cited by this paper
• Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma

  2014cited by this paper
• Molecular insights into the association of obesity with breast cancer risk: relevance to xenobiotic metabolism and CpG island methylation of tumor suppressor genes

  2014cited by this paper
• A Common Polymorphism in Extracellular Superoxide Dismutase Affects Cardiopulmonary Disease Risk by Altering Protein Distribution

  2014cited by this paper
• Role of epigenetics in pulmonary hypertension.

  2014cited by this paper
• Sirtuin 3 deficiency is associated with inhibited mitochondrial function and pulmonary arterial hypertension in rodents and humans.

  2014cited by this paper
• Histone Deacetylase Inhibitors Modulate the Transcriptional Regulation of Guanylyl Cyclase/Natriuretic Peptide Receptor-A Gene

  2014cited by this paper
• Sirtuin 3 deficiency does not augment hypoxia-induced pulmonary hypertension.

  2013cited by this paper
• Role of histone deacetylases in regulation of phenotype of ovine newborn pulmonary arterial smooth muscle cells

  2013cited by this paper
• Epigenetic Regulation of Vascular Smooth Muscle Cell Function in Atherosclerosis

  2013cited by this paper
• Epigenetic regulation of extracellular-superoxide dismutase in human monocytes.

  2013cited by this paper
• Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy

  2013cited by this paper
• Histone Deacetylation Inhibition in Pulmonary Hypertension: Therapeutic Potential of Valproic Acid and Suberoylanilide Hydroxamic Acid

  2012cited by this paper
• Selective Class I Histone Deacetylase Inhibition Suppresses Hypoxia-Induced Cardiopulmonary Remodeling Through an Antiproliferative Mechanism

  2012cited by this paper
• Histone Deacetylase 3 Mediates Allergic Skin Inflammation by Regulating Expression of MCP1 Protein*

  2012cited by this paper
• Extracellular Superoxide Dismutase Overexpression Can Reverse the Course of Hypoxia-Induced Pulmonary Hypertension

  2012cited by this paper
• Oxidative stress in coronary artery disease: epigenetic perspective

  2012cited by this paper
• Histone acetylation regulates the cell-specific and interferon-γ-inducible expression of extracellular superoxide dismutase in human pulmonary arteries.

  2011cited by this paper
• Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension.

  2011cited by this paper
• Genetic and Epigenetic Inactivation of Extracellular Superoxide Dismutase Promotes an Invasive Phenotype in Human Lung Cancer by Disrupting ECM Homeostasis

  2011cited by this paper
• Lung extracellular superoxide dismutase overexpression lessens bleomycin-induced pulmonary hypertension and vascular remodeling.

  2011cited by this paper
• Exacerbated Pulmonary Arterial Hypertension and Right Ventricular Hypertrophy in Animals With Loss of Function of Extracellular Superoxide Dismutase

  2011cited by this paper
• Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats.

  2011cited by this paper
• Polymorphisms in the Superoxide Dismutase-3 Gene Are Associated with Emphysema in COPD

  2010cited by this paper
• Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line

  2010cited by this paper
• Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.

  2010cited by this paper
• Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in Pulmonary Arterial Hypertension: A Basis for Excessive Cell Proliferation and a New Therapeutic Target

  2010cited by this paper
• CpG methylation attenuates Sp1 and Sp3 binding to the human extracellular superoxide dismutase promoter and regulates its cell-specific expression.

  2010cited by this paper
• SOD3 R231G polymorphism associated with coronary artery disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study

  2009cited by this paper
• Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion.

  2009cited by this paper
• Inflammation, growth factors, and pulmonary vascular remodeling.

  2009cited by this paper
• Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations.

  2008cited by this paper
• Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling.

  2008cited by this paper
• Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells.

  2008cited by this paper
• Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats.

  2008cited by this paper
• Transcription factors sp1 and sp3 regulate expression of human extracellular superoxide dismutase in lung fibroblasts.

  2008cited by this paper
• Deficiency of Lung Antioxidants in Idiopathic Pulmonary Arterial Hypertension

  2008cited by this paper
• Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines

  2007cited by this paper
• Epigenetic Regulation of Manganese Superoxide Dismutase Expression in Human Breast Cancer Cells

  2006cited by this paper
• Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes.

  2006cited by this paper
• Histone deacetylase 3 represses p15(INK4b) and p21(WAF1/cip1) transcription by interacting with Sp1.

  2006cited by this paper
• Extracellular superoxide dismutase.

  2005cited by this paper
• Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.

  2004cited by this paper
• Genetically Reduced Antioxidative Protection and Increased Ischemic Heart Disease Risk: The Copenhagen City Heart Study

  2003cited by this paper
• The dual nature of human extracellular superoxide dismutase: One sequence and two structures

  2003cited by this paper
• Depletion of pulmonary EC-SOD after exposure to hyperoxia.

  2002cited by this paper
• Extracellular superoxide dismutase in vessels and airways of humans and baboons.

  1996cited by this paper
• Extracellular superoxide dismutase: a regulator of nitric oxide bioavailability.

  1996cited by this paper

• Histone deacetylase 3 promotes hypoxia-induced human pulmonary arterial smooth muscle cell proliferation by modulating the CSF2-JAK2-STAT5 signaling pathway

  2026cites this paper
• Extracellular Superoxide Dismutase in Acute Respiratory Distress Syndrome: Pathogenic Mechanisms and Therapeutic Implications.

  2026cites this paper
• Role of Histone Deacetylase and Inhibitors in Cardiovascular Diseases

  2025cites this paper
• Rewriting the vascular script: epigenetic modifiers as scribes of metabolic reprogramming in pulmonary hypertension

  2025cites this paper
• HDAC6 inhibition upregulates endothelial SOD3 expression via Sp1 acetylation and attenuates angiotensin II‐induced hypertension

  2025cites this paper
• Inhibition of HDAC6 elicits anticancer effects on head and neck cancer cells through Sp1/SOD3/MKP1 signaling axis to downregulate ERK phosphorylation.

  2025cites this paper
• Citrate: a key signalling molecule and therapeutic target for bone remodeling disorder

  2025cites this paper
• Vascular EC-SOD limits the accumulation, proinflammatory profibrotic reprogramming, and hyaluronan binding of interstitial macrophages in hypoxia

  2025cites this paper
• Redistribution of SOD3 expression due to R213G polymorphism affects pulmonary interstitial macrophage reprogramming in response to hypoxia.

  2024cites this paper
• CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial

  2024cites this paper
• Epigenetics mechanism and therapeutic potential of approved epi-drugs in pulmonary hypertension disease.

  2023cites this paper
• The role of HDAC3 and its inhibitors in regulation of oxidative stress and chronic diseases

  2023cites this paper
• Targeting oxidative stress as a preventive and therapeutic approach for cardiovascular disease

  2023cites this paper
• Integrating Epigenetics and Metabolomics to Advance Treatments for Pulmonary Arterial Hypertension.

  2022cites this paper
• The alveolar epithelial cells are involved in pulmonary vascular remodeling and constriction of hypoxic pulmonary hypertension

  2021cites this paper
• Management of oxidative stress and inflammation in cardiovascular diseases: mechanisms and challenges

  2021cites this paper
• Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy.

  2021cites this paper
• Protein acetylation in cardiac aging.

  2021cites this paper
• Histone deacetylase inhibitors for cardiovascular conditions and healthy longevity.

  2021cites this paper
• Alteration of Extracellular Superoxide Dismutase in Idiopathic Pulmonary Arterial Hypertension

  2020influential citation
• Altered expression of norepinephrine transporter participate in hypertension and depression through regulated TNF-α and IL-6

  2020cites this paper
• Extracellular superoxide dismutase (SOD3): An antioxidant or prooxidant in the extracellular space?

  2020cites this paper
• Extracellular Superoxide Dismutase Regulates Early Vascular Hyaluronan Remodeling in Hypoxic Pulmonary Hypertension

  2020cites this paper
• Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review.

  2020cites this paper
• Beyond the Genome: Challenges and Potential for Epigenetics-driven Therapeutic Approaches in Pulmonary Arterial Hypertension.

  2020cites this paper
• Epigenetics and pulmonary diseases in the horizon of precision medicine: a review

  2020cites this paper
• Integrated Bioinformatic Approach to Identify Potential Biomarkers against Idiopathic Pulmonary Fibrosis

  2019cites this paper
• Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension

  2019cites this paper
• Epigenetic Inheritance Underlying Pulmonary Arterial Hypertension: A New Challenge for Network Medicine

  2019cites this paper
• Effect of Oxidative Stress on the Estrogen-NOS-NO-KCa Channel Pathway in Uteroplacental Dysfunction: Its Implication in Pregnancy Complications

  2019cites this paper
• The dynamic uptake and release of SOD3 from intracellular stores in macrophages modulates the inflammatory response

  2019cites this paper
• Epigenetic Modulation in the Initiation and Progression of Pulmonary Hypertension.

  2019influential citation
• Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy

  2019cites this paper
• Emerging therapeutics in pulmonary hypertension.

  2018cites this paper
• Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension

  2018cites this paper
• R213G polymorphism in SOD3 protects against bleomycin-induced inflammation and attenuates induction of proinflammatory pathways.

  2018cites this paper
• Phosphatidylinositol 3‐Kinase–DNA Methyltransferase 1–miR‐1281–Histone Deacetylase 4 Regulatory Axis Mediates Platelet‐Derived Growth Factor–Induced Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells

  2018cites this paper
• Extracellular superoxide dismutase and its role in cancer.

  2017cites this paper
• Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia.

  2017cites this paper
• Emerging Metabolic Therapies in Pulmonary Arterial Hypertension

  2017cites this paper
• Redox Regulation of the Superoxide Dismutases SOD3 and SOD2 in the Pulmonary Circulation.

  2017cites this paper
• The Epigenetic Machinery in Vascular Dysfunction and Hypertension

  2017cites this paper
• Critical effects of epigenetic regulation in pulmonary arterial hypertension

  2017cites this paper
• Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease.

  2016cites this paper
• Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.

  2016cites this paper
• Update on novel targets and potential treatment avenues in pulmonary hypertension.

  2016cites this paper